Chikungunya vaccine, live (cvx 317) Disease Interactions
There is 1 disease interaction with chikungunya vaccine, live (cvx 317).
Moderate
Vaccines (live attenuated/toxoid) (applies to chikungunya vaccine, live (cvx 317)) immunocompromised
Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Immunodeficiency
The expected antibody responses may not be obtained when live attenuated vaccines and/or toxoids are administered to immunosuppressed persons, including those receiving immunosuppressive therapy. Caution and close monitoring is advised.
Switch to professional interaction data
Chikungunya vaccine, live (cvx 317) drug interactions
There are 341 drug interactions with chikungunya vaccine, live (cvx 317).
Report options
QR code containing a link to this page
More about chikungunya vaccine, live (cvx 317)
- chikungunya vaccine, live (cvx 317) consumer information
- Check interactions
- Compare alternatives
- Latest FDA alerts (1)
- Side effects
- Dosage information
- During pregnancy
- Drug class: viral vaccines
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
